Apoptosis in Neurodegenerative Disorders.

Yoshikuni Mizuno, Hideki Mochizuki, Y Sugita, Keigo Goto

Internal Medicine · 1998 · 21 citations · 21 references

DOIFull text

Open access

Concepts

Abstract

not observed for the mature form, and that proHB-EGFmay act as a tumor survival factor in hepatoma cells. Hepatomasat the earliest stage do not always need rapid growth, but it is necessary for escape from various immune systems. Resistance against several factors may play a role in the early progression of hepatomas. A hepatoma overexposing proHB-EGFshowed strong resistance to several factors. Although the mechanismunderlying resistance to TGFp-induced apoptosis remain unknown, the resistance to serum-starved treatment is thought to be due to Gl arrest induced by upregulation ofp21. In somecases, cells under Gl arrest undergo apoptosis. However, PHB-AHcells showed slow growth with a high percentage of the Gl phase in the cell cycle. Thus, proHB-EGFspecifically may act as a cell survival factor in liver tissues.

References

21